Live Pfizer updates

Live Pfizer news coverage of developments with the latest updates. Stay on top of latest Pfizer news stories and find out what just happened, what is going on with Pfizer. The latest real-time news updates and headlines on Pfizer
Research Reveals Why Some Prostate Tumors Resist Treatment
More Support Needed for Quitting Vaping: Strategies Here
US Brain Gain Threatened, Jeopardizing Prosperity
Uterine Cancer Rates Set to Surge, Impacting Black Women
Cholesterol Drugs Could Prevent Thousands of Heart Attacks
Pfizer Reveals Positive Phase 3 Results for HYMPAVZI
Pfizer Announces Q3 2025 Dividend
BRACELET-1 Trial: Pelareorep Boosts Chemo in Breast Cancer
COVID Vax Cuts Dialysis, Boosts Survival in Kidney Injury
RFK Jr's Shakeup Of Vaccine Advisory Committee Raises Worries About Scientific Integrity Of Health Recommendations
Funding Awarded To Research On Cluster Headache
HMPV: Winter Illness Alert, Know Virus Facts
UK Aims for Drug Discovery Lead at London Tech Week
UConn Pharmacy Boosts Pharma Career Awareness
ODA Cuts Deepen Neglect of Tropical Diseases
New Blood Epigenetic Clock Targets Aging Capacity
Vepdegestrant Boosts Survival in Advanced Breast Cancer
Pfizer Combo Halves Death Risk in BRAF V600E Cancer
Triple Therapy Boosts Survival in BRAF V600E Colon Cancer
ASCO: Triple Therapy Boosts Survival in Metastatic Colorectal Cancer
Key Long COVID Symptoms Found in Young Children
City of Hope to Unveil Cancer Breakthroughs at ASCO
Top Cardiologist Urges Global Heart Health Revamp
Phytomedicine's Dual Role: Long COVID and Heart Health
Lipid Nanoparticle Structure Unveiled for Better Delivery
Breakthrough in Lipid Nanoparticles for Vaccines
CCM Biosciences Unveils AML Drug Data at ASCO 2025
Pfizer Secures Exclusive Licensing Deal With 3SBio
Mucus Plugs Tied to Rapid COPD Lung Decline
Supervising For Success
Business Leaders Appointed to Manage Key Suppliers
Dose Of Hi Pioneers Of UConn Pharmacy
Tailored Biopsies Boost Patient Outcomes
Vaccine Arm Choice Key to Immune Response: Study
Pfizer Combo Boosts Survival in High-Risk Bladder Cancer
Pfizer Unveils 2025 Shareholder Meeting Results
Pfizer Unveils Bold Cancer Care Vision at ASCO 2025
Pfizer Announces Q2 2025 Dividend
Older Adults Thrive on Immunotherapy Despite Age Gaps
Immunotherapy Effective in Seniors Despite Immune Changes
ACIP Expands Pfizer RSV Vaccine for At-Risk Adults 50-59
Public Records Staff Cuts Risk Government Accountability
Pfizer Updates on Oral GLP-1 Drug Danuglipron
New Immune Cell Discovery Sheds Light on Food Allergies
Pfizer Sets Virtual 2025 Shareholders Meeting for April 24
Innovating Health's Future Through Entrepreneurship
US Vaccine Investment Yields Strong Returns
EU Approves Pfizer's ABRYSVO RSV Vaccine for Adults 18-59